News about Global Pharma

PredxBio and Hamamatsu Partner to Advance Spatial Biology for Cancer Research

PredxBio and Hamamatsu Partner to Advance Spatial Biology for Cancer Research

PredxBio, an AI-driven spatial biomarker discovery company, has entered into a strategic collaboration with Hamamatsu Photonics to combine advanced imaging and analytics technologies for accelerating cancer research and immuno-oncology discoveries.

Global Pharma | 29/04/2025 | By Manvi 273

Nipro India Unveils Glass Cartridge Expansion at Pune Plant

Nipro India Unveils Glass Cartridge Expansion at Pune Plant

The Nipro Pune plant is an experienced manufacturing site that has been producing premium-quality glass containers for leading Indian and global pharmaceutical companies for years.

Global Pharma | 29/04/2025 | By Abha 614

Morepen to Expand Portfolio with Launch of Resmetirom for Fatty Liver Disease

Morepen to Expand Portfolio with Launch of Resmetirom for Fatty Liver Disease

Morepen Laboratories Ltd. has received approval from the Subject Expert Committee (SEC) of the CDSCO to initiate Bioequivalence studies for Resmetirom, a promising new therapy for non-alcoholic steatohepatitis (NASH), marking a key step in its expansion into the hepatology segment.

Global Pharma | 29/04/2025 | By Manvi 488

Healthy.io Signs Agreement to Acquire Labrador Health

Healthy.io Signs Agreement to Acquire Labrador Health

This strategic acquisition marks a step forward in Healthy.io's mission of transforming home-based diagnostics with lab-quality accuracy, powered by the smartphone.

Global Pharma | 29/04/2025 | By Manvi 190

GammaPod Breast Cancer Treatment Debuts in Europe with Tema Sinergie

GammaPod Breast Cancer Treatment Debuts in Europe with Tema Sinergie

GammaPod, one of the most advanced innovations in the treatment of breast cancer, officially arrives in Europe thanks to the commitment of Tema Sinergie SpA, an Italian company based in Faenza.

Global Pharma | 29/04/2025 | By Manvi 204

Biocon Biologics Gets Positive CHMP Opinions for Biosimilar Denosumab in Europe

Biocon Biologics Gets Positive CHMP Opinions for Biosimilar Denosumab in Europe

Biocon Biologics has received positive CHMP opinions recommending approval of its denosumab biosimilars, Vevzuo and Denosumab BBL, for bone health indications in Europe.

Global Pharma | 28/04/2025 | By Manvi 237

GemPharmatech Opens New San Diego Biotech Hub Facility

GemPharmatech Opens New San Diego Biotech Hub Facility

GemPharmatech has opened its newly expanded US headquarters in San Diego, featuring a state-of-the-art vivarium and lab space to enhance preclinical research support for the North American biomedical community.

Global Pharma | 28/04/2025 | By Manvi 264

Ormco Launches Spark Retainers and BiteSync Class II Corrector in US at AAO 2025

Ormco Launches Spark Retainers and BiteSync Class II Corrector in US at AAO 2025

Developed for doctors and patients, Spark Retainers bring a new level of comfort, durability, and clinical flexibility to orthodontic retainers whether treating with Spark™ Clear Aligners, Ormco™ Digital Bonding, or fixed brackets.

Global Pharma | 28/04/2025 | By Manvi 800

SS Innovations Lists on NASDAQ, Marking Global Milestone for Indian Surgical Robotics

SS Innovations Lists on NASDAQ, Marking Global Milestone for Indian Surgical Robotics

SS Innovations International has made remarkable progress with its clinically validated and patented SSI Mantra Surgical Robotic System, which has been installed in 80 hospitals across 75 locations in India, as well as expanding its footprint in countries including Nepal, Ecuador, Guatemala, the Philippines, Indonesia, Sri Lanka, and Ukraine.

Global Pharma | 28/04/2025 | By Manvi 448

Life Molecular Imaging's Neuraceq Now Available at PharmaLogic's Salt Lake City Facility

Life Molecular Imaging's Neuraceq Now Available at PharmaLogic's Salt Lake City Facility

Life Molecular Imaging and PharmaLogic have expanded their strategic partnership to produce and distribute Neuraceq from PharmaLogic’s Salt Lake City facility, with commercial doses available from April 23, 2025.

Global Pharma | 25/04/2025 | By Manvi 208

 
 

 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members